相关实验视频
Updated: Jul 13, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
临床上显著的生殖系病原体变异被瘤基因组测序遗漏
Leigh Anne Stout1,2, Cynthia Hunter2, Courtney Schroeder2
1Indiana University School of Medicine, Indianapolis, IN, USA.
NPJ genomic medicine
|October 13, 2023
概括
由于测试方法的差异,瘤基因组测序可能会错过生殖系病原体变异. 完成生殖线和体质检测对于准确的癌症诊断和治疗决策至关重要.
科学领域:
- 基因组医学是基因组医学.
- 在瘤学瘤学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 瘤基因组测序 (体检) 对于有针对性的治疗选择至关重要.
- 生殖系致病变体,癌症的遗传性倾向,可以告知治疗和风险管理.
- 身体和生殖线检测之间的差异可能导致错过诊断.
研究的目的:
- 强调考虑生殖系致病变体的重要性,即使体检结果是阴性.
- 解释胚胎系和体系实验室之间测试设计和变异报告的关键差异.
- 强调进行生殖系和体质遗传测试的临床实用性.
主要方法:
- 对生殖系和体质遗传检测方法的比较分析.
- 对生殖系与体质突变的变异解释指南的审查.
- 临床案例示例说明了组合测试的影响.
主要成果:
- 身体和生殖系遗传测试试验具有不同的设计和报告标准.
- 瘤测序可能无法检测出所有生殖系致病变体.
- 识别生殖系变异对于个性化癌症护理至关重要.
结论:
- 尽管瘤基因组测序结果是负的,但生殖系病原体变异可能存在.
- 生殖线和体质遗传测试都是必要的,以全面评估患者.
- 综合测试指导最佳治疗策略,查方案和降低风险的干预措施.
相关概念视频
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K

